The present invention provides a blood glucose system having time synchronization, wherein the blood glucose system (1) for treating a glucose metabolic disorder includes a dosing device (3) having an integrated counter for generating a relative count and a memory for storing dose quantities and counts, a blood glucose measuring device (2) having memory for storing blood glucose measurements and measurement times, and a data processor (4) for processing data from the dosing device (3) and blood glucose measuring device (2) and converting counts to actual times. The data processor synchronizes the counts with the measurement times using a time standard.
The invention discloses panax ginseng stem leaf effective parts, an extracting method thereof and application of the panax ginseng stem leaf effective parts in lowering the blood glucose, and belongsto the field of drugs. The panax ginseng stem leaf effective parts comprise, by mass, 1-30% of ginsenoside Rg1, 10-40% of ginsenoside Re, 1-20% of ginsenoside Rb2 and 1-30% of ginsenoside Rd. The invention further discloses the extracting method of the panax ginseng stem leaf effective parts and the application of the panax ginseng stem leaf effective parts in treating diabetes. The panax ginsengstem leaf effective parts can correct glucose metabolic disorders, lower fasting blood glucose, reduce impaired glucose tolerance, improve insulin resistance and insulin sensitivity, and have the function of treating or preventing diabetes and complications of the diabetes.
The invention discloses application of Baatimatat to preparation of a medicine for preventing and treating obesity and secondary bone loss. According to the invention, a mouse high-fat dietobesity model is utilized to simulate the most common primary obesity in people; the in-vivo biological efficacy of the Batimatat is evaluated through multiple dimensions such as weight, glycometabolism, adipose tissue change, bone metabolism and the like; the fact that the Batimatat can be applied to prevention and treatment of obesity caused by over-differentiation and accumulation of adipocytes and concomitant complications of glucose metabolic disorders, osteopenia and the like is defined for the first time; and the Batimatat takes a relatively remarkable effect.